Evidence map›Paper›PMID 34504684›Full record

ArticleF1000Research2021

Substantial impact of post-vaccination contacts on cumulative infections during viral epidemics.

Nash Rochman, Yuri Wolf, Eugene V Koonin

Abstract read
In one paragraph

Article in F1000Research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Targeted vaccination and the speed of SARS-CoV-2 adaptation.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  5. Article
  6. Article
  7. Ongoing global and regional adaptive evolution of SARS-CoV-2.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  8. Ongoing Global and Regional Adaptive Evolution of SARS-CoV-2.bioRxiv : the preprint server for biology · 2021
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nash RochmanNational Center for Biotechnology Information, NIH, Bethesda, MD, 20894, USA.ORCID 0000-0002-7991-8505
Yuri WolfNational Center for Biotechnology Information, NIH, Bethesda, MD, 20894, USA.
Eugene V KooninNational Center for Biotechnology Information, NIH, Bethesda, MD, 20894, USA.ORCID 0000-0003-3943-8299

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19EpidemicsCOVID-19 VaccinesHumansSARS-CoV-2VaccinationCOVID-19 VaccinesVirus infection; epidemics; vaccination; escape mutants; contact limitation

Identifiers

PMID34504684
PMCPMC8406440.2

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.